Karyopharm Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2013
Total Assets: $158.2M
Liabilities Breakdown FY2013
Total Liabilities: $3.3M
Asset Breakdown
Total Assets: $158.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $156.0M | 98.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $240.0K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.0M | 1.3% |
Liabilities Breakdown
Total Liabilities: $3.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 52.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.6M | 47.1% |